GlassScriptPhysician profile
Debra L Dresden
NPI 1336177070
$729.82
in general payments reported to CMS, 2019-2025
12 companies · $19.98 in 2025
The $19.98 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $537 · 2024: $18.32 · 2025: $19.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $19.98 · Food and Beverage: $18.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $19.98 |
| Food and Beverage | $18.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $192.18 | 2022 | |
| Boston Scientific Corporation | $149.42 | 2022 | |
| Lilly USA, LLC | $81.70 | 2021-2022 | |
| Abbott Laboratories | $65.57 | 2022-2025 | Freestyle Insulinx |
| Novo Nordisk INC | $53.51 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $50.71 | 2021-2022 | |
| Amarin Pharma, INC. | $48.21 | 2022 | |
| Mannkind Corporation | $23.43 | 2022 | |
| Dexcom, INC. | $20.57 | 2021 | |
| Radius Health, INC. | $18.32 | 2024 | Tymlos |
| Vistapharm, INC. | $13.45 | 2021 | |
| Insulet Corporation | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Dresden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.